Large differences in adiponectin levels have no clear effect on multiple sclerosis risk:A Mendelian randomization study

Autor: Lauren E. Mokry, John A. Morris, Stephen Sawcer, George Davey Smith, J. Brent Richards, Vincenzo Forgetta, Julia Devorak

Publikováno v: Devorak, J, Mokry, L E, Morris, J A, Forgetta, V, Davey Smith, G, Sawcer, S J & Richards, J B 2017, ' Large differences in adiponectin levels have no clear effect on multiple sclerosis risk : A Mendelian randomization study ', Multiple Sclerosis Journal, vol. 23, no. 11, pp. 1461-1468 . https://doi.org/10.1177/1352458516681196

Background: Mendelian randomization (MR) studies have demonstrated strong support for an association between genetically increased body mass index and risk of multiple sclerosis (MS). The adipokine adiponectin may be a potential mechanism linking bod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c09cc767dc7f8d28a53962bdc035206
https://hdl.handle.net/1983/5d5648ae-21fd-464f-a93f-243fb429aa8c